All data are based on the daily closing price as of November 22, 2024
t
Towa Pharmaceutical
4553.TSE
18.22 USD
-0.08
-0.44%
Overview
Last close
18.22 usd
Market cap
896.95M usd
52 week high
21.58 usd
52 week low
11.94 usd
Target price
23.56 usd
Valuation
P/E
8.7952
Forward P/E
16.7785
Price/Sales
0.5883
Price/Book Value
0.8725
Enterprise Value
2.06B usd
EV/Revenue
1.3042
EV/EBITDA
7.1481
Key financials
Revenue TTM
1.53B usd
Gross Profit TTM
469.97M usd
EBITDA TTM
242.92M usd
Earnings per Share
2.07 usd
Dividend
N/A usd
Total assets
2.81B usd
Net debt
1.11B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.